USANA Health Sciences, Inc
Price
FilingsNewest: 8-K, Material agreementOct 5 →InsidersNo open-market buys. 9 insiders sold $990,588, 0 of 17 sales on a 10b5-1 plan.→HoldersNantahala 8.8%BlackRock 8.4%Pzena 6.5%→PeersClosest companies: NUS, HLF, LFVN→
From the filings
Figures
- Revenue
- $925.9Mlast 12 months
- Net income
- $8.9Mlast 12 months
- Operating cash flow
- $16.6Mlast 12 months
- Cash and equivalents
- $168.6Mat the last balance sheet
- Shares outstanding
- 18.5M shareson issue